# Dexmedetomidine in Attenuation of Haemodynamic Response to Laryngoscopy in Controlled Hypertensive Patients

> **NCT07557680** · PHASE3 · COMPLETED · sponsor: **Sindh Institute of Urology and Transplantation** · enrollment: 70 (actual)

## Conditions studied

- Hypertension
- Hemodynamic Response
- Anesthesia

## Interventions

- **DRUG:** Dexmedetomidine
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT07557680
- **Lead sponsor:** Sindh Institute of Urology and Transplantation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07557680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07557680, "Dexmedetomidine in Attenuation of Haemodynamic Response to Laryngoscopy in Controlled Hypertensive Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07557680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*